Direxion Daily LLY Bear 1X Shares (ELIS) seeks to provide inverse exposure to Eli Lilly and Company (LLY) stock, delivering returns that move opposite to the pharmaceutical giant's daily performance. This single-stock inverse ETF targets one of the world's largest diabetes and obesity treatment companies.
How It Works
ELIS uses derivatives including swaps and futures contracts to generate inverse returns equal to -100% of LLY's daily price movements. The fund resets its exposure daily, meaning it aims to deliver inverse performance only for single-day periods. Holdings consist primarily of cash collateral and derivative instruments rather than actual stocks. Daily rebalancing ensures the fund maintains its -1x target exposure regardless of LLY's price fluctuations.
Key Features
- Provides precise -1x inverse exposure to Eli Lilly without requiring margin account or short-selling capabilities
- Daily reset mechanism ensures consistent -100% target exposure regardless of underlying stock volatility
- Focuses on single pharmaceutical stock known for diabetes drugs Mounjaro and weight-loss treatment Zepbound
Risks
- This ETF loses value when Eli Lilly stock rises, potentially declining 20-30% if LLY surges on positive drug trial results or FDA approvals
- Daily rebalancing causes compounding decay over multiple days—if LLY drops 10% then rises 10%, this ETF does not return to break-even
- Single-stock concentration means pharmaceutical sector news, drug pipeline developments, or regulatory changes create extreme volatility exceeding 5-10% daily moves
Who Should Own This
Designed for sophisticated traders with high risk tolerance seeking short-term hedging or speculation against Eli Lilly stock over hours to days, not weeks or months. Suitable as tactical position representing less than 5% of portfolio. Requires active monitoring and quick exit strategy due to daily reset effects.